Terns Pharmaceuticals, Inc. (TERN)
52.86
+2.86
(+5.72%)
USD |
NASDAQ |
Mar 25, 16:00
53.09
+0.23
(+0.44%)
After-Hours: 20:00
Terns Pharmaceuticals Free Cash Flow : -77.99M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Cogent Biosciences, Inc. | -266.00M |
| BioMarin Pharmaceutical, Inc. | 717.02M |
| ADMA Biologics, Inc. | 27.50M |
| Arcellx, Inc. | -212.58M |
| Corcept Therapeutics, Inc. | 141.78M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -19.77M |
| Cash from Investing (Quarterly) | 24.50M |
| Free Cash Flow Per Share (Quarterly) | -0.2156 |
| Free Cash Flow to Equity (Quarterly) | -19.67M |
| Free Cash Flow to Firm (Quarterly) | -19.77M |
| Free Cash Flow Yield | -1.61% |